Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01275677
What this trial is testing

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Who this might be right for
HER2/Neu PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+6 more
National Cancer Institute (NCI) 3,270
Early research (Phase 1)WithdrawnNCT03612466
What this trial is testing

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Who this might be right for
OsteosarcomaBone Metastases
Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Large-scale testing (Phase 3)Looking for participantsNCT06492460
What this trial is testing

2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Sun Yat-sen University 422
Large-scale testing (Phase 3)Study completedNCT03404648
What this trial is testing

Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI

Who this might be right for
Prostate Adenocarcinoma
Mayo Clinic 19
Large-scale testing (Phase 3)Ended earlyNCT02974426
What this trial is testing

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIARadiotherapy
Shanghai Chest Hospital 132
Testing effectiveness (Phase 2)Study completedNCT00387868
What this trial is testing

Preoperative Treatment of Patients With High Risk Thymoma

Who this might be right for
Thymoma
Valley Health System 21
Not applicableEnded earlyNCT02705924
What this trial is testing

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Centre Jean Perrin 32
Testing effectiveness (Phase 2)Ended earlyNCT01534143
What this trial is testing

High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Barbara Ann Karmanos Cancer Institute 1
Not applicableNot Yet RecruitingNCT06728150
What this trial is testing

Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticBrain Metastasases
Monash University 45
Not applicableStudy completedNCT01905891
What this trial is testing

Nanocytology Test to Evaluate Skin Cancer in High Risk Patients

Who this might be right for
Actinic KeratosisSquamous Cell Carcinoma
Northwestern University 7
Testing effectiveness (Phase 2)UnknownNCT05223582
What this trial is testing

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Who this might be right for
High-risk Prostate CancerNeoadjuvant Therapy
Fudan University 34
Large-scale testing (Phase 3)Study completedNCT00379340
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Who this might be right for
Stage III Kidney Wilms TumorStage IV Kidney Wilms Tumor
Children's Oncology Group 395
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Very early researchUnknownNCT03795779
What this trial is testing

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more
iCell Gene Therapeutics 20
Not applicableUnknownNCT04818476
What this trial is testing

Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's Esophagus

Who this might be right for
Barrett EsophagusAdenocarcinoma EsophagusSubmucosal Esophageal Adenocarcinoma+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06172296
What this trial is testing

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Who this might be right for
Ganglioneuroblastoma, NodularNeuroblastoma
National Cancer Institute (NCI) 478
Not applicableLooking for participantsNCT07219303
What this trial is testing

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center 80
Testing effectiveness (Phase 2)Ended earlyNCT00851110
What this trial is testing

Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

Who this might be right for
High-Risk Breast Cancer
University Medical Center Groningen 50
Testing effectiveness (Phase 2)Study completedNCT00019890
What this trial is testing

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
National Cancer Institute (NCI)
Next Page